GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 1 filers reported holding GENOMIC HEALTH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $405,000 | +13400.0% | 5,970 | +5870.0% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -83.3% | 100 | -83.3% | 0.00% | – |
| Q4 2016 | $18,000 | 0.0% | 600 | -4.9% | 0.00% | – |
| Q3 2016 | $18,000 | +500.0% | 631 | +531.0% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -95.3% | 100 | -92.9% | 0.00% | – |
| Q1 2015 | $43,000 | -4.4% | 1,400 | 0.0% | 0.00% | – |
| Q4 2014 | $45,000 | -4.3% | 1,400 | -15.2% | 0.00% | -100.0% |
| Q3 2014 | $47,000 | +23.7% | 1,650 | +17.9% | 0.00% | – |
| Q2 2014 | $38,000 | +2.7% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q1 2014 | $37,000 | +85.0% | 1,400 | +100.0% | 0.00% | – |
| Q4 2013 | $20,000 | -4.8% | 700 | 0.0% | 0.00% | – |
| Q3 2013 | $21,000 | -4.5% | 700 | 0.0% | 0.00% | -100.0% |
| Q2 2013 | $22,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,744,010 | $756,432,000 | 6.19% |
| EMORY UNIVERSITY | 30,319 | $1,953,000 | 1.54% |
| Copper Rock Capital Partners, LLC | 292,596 | $18,630,000 | 1.46% |
| DE BURLO GROUP INC | 73,600 | $4,740,000 | 1.06% |
| Eversept Partners, LP | 23,866 | $1,537,209 | 0.83% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 165,310 | $10,648,000 | 0.83% |
| Aurora Investment Counsel | 20,916 | $1,347,000 | 0.73% |
| Texas Children's | 8,035 | $518,000 | 0.72% |
| Capital Impact Advisors, LLC | 24,665 | $1,570,000 | 0.67% |
| Granahan Investment Management | 130,650 | $8,415,000 | 0.60% |